Neurology Devices Market Trends, Share Analysis, Growth Factors, and Forecast 2025-2033

Market Overview

The global [neurology devices market](https://wordhtml.com/(https://www.imarcgroup.com/neurology-devices-market) size reached USD 14.4 Billion in 2024 and is expected to grow to USD 26.6 Billion by 2033. This growth represents a CAGR of 6.72% during the forecast period of 2025-2033. Key factors driving the market include rising prevalence of neurological disorders such as epilepsy, Alzheimer’s disease, and cerebrovascular diseases, advancements in device technology, and the increasing geriatric population.

Study Assumption Years

• Base Year: 2024
• Historical Years: 2019-2024
• Forecast Period: 2025-2033

Neurology Devices Market Key Takeaways

• Current Market Size: USD 14.4 Billion in 2024
• CAGR: 6.72% during 2025-2033
• Forecast Period: 2025-2033
• Market growth is supported by favorable government initiatives and expansion of healthcare facilities.
• Increasing incidences of neurological disorders and the growing geriatric population are major demand drivers.
• North America dominates the market due to advanced healthcare infrastructure.
• Regulatory hurdles pose a challenge, while opportunities arise from developments in regenerative medicine and restorative therapies.
• The market includes key product segments such as neurostimulation devices, which hold the largest share.

Sample Request Link: https://www.imarcgroup.com/neurology-devices-market/requestsample

Market Growth Factors

The global neurology devices market is propelled by the rising prevalence of neurological disorders such as epilepsy, Alzheimer’s disease, dementias, and cerebrovascular diseases. According to the World Health Organization (WHO), diabetic neuropathy affected 206 million people in 2021. These conditions often result from genetic disorders, infections, congenital abnormalities, lifestyle health problems, and injuries affecting the brain, spinal cord, and nerves. Neurology devices facilitate precise diagnosis through detailed visualization and monitoring of brain activity.

Technological advancements are enhancing the functionality and capabilities of neurology devices. Leading companies are introducing innovative devices with telemedicine features that allow remote patient monitoring. For example, Abbott’s NeuroSphereTM myPathTM digital health app received an update in April 2022 to improve patient monitoring during treatments like dorsal root ganglion or spinal cord stimulation therapy. Such innovations contribute significantly to market growth.

The increasing geriatric population worldwide also boosts demand for neurology devices. Older adults are more susceptible to neurological conditions such as dementia, stroke, Parkinson’s disease, and Alzheimer’s disease, thus requiring more medical attention and specialized equipment. The World Health Organization estimates the number of people aged 80 years or older to reach 426 million by 2050, indicating a growing need for these medical devices.

Market Segmentation

Breakup by Product:

• Neurostimulation Devices: Represent the largest segment; crucial for nerve stimulation and managing neural pathway disorders through medication, electrical signals, or energy. They offer customizable treatments and may reduce the need for medication.
• Neurosurgery Devices
• Interventional Neurology Devices
• Cerebrospinal Fluid Management Devices
• Others

Breakup by End User:

• Hospitals: Account for the largest market share; equipped with infrastructure and specialist personnel to treat neurological disorders.
• Ambulatory Surgery Centers
• Neurology Clinics

Breakup by Region:

• North America: Includes the United States and Canada.
• Asia-Pacific: Comprising China, Japan, India, South Korea, Australia, Indonesia, and others.
• Europe: Covering Germany, France, the United Kingdom, Italy, Spain, Russia, and others.
• Latin America: Including Brazil, Mexico, and others.
• Middle East and Africa

Regional Insights

North America leads the global neurology devices market owing to the presence of advanced healthcare facilities and modern medical technologies. The region benefits from intense research and development efforts that foster innovation in neurology device technologies. Favorable government initiatives and the high prevalence of neurological conditions contribute to North America holding the largest market share. For instance, it is projected that around 13 million Americans will suffer from Alzheimer's disease by 2050.

Recent Developments & News

Significant recent developments include Medtronic plc announcing the first enrollment in its Adaptive DBS Algorithm for Personalized Therapy in Parkinson’s Disease (ADAPT-PD) trial on 14 January 2021, evaluating adaptive deep brain stimulation (aDBS) safety and efficacy. On 12 January 2021, ClearMind Biomedical received FDA 510k clearance for its Axonpen System neuroendoscope, designed for intracranial tissue illumination, visualization, and fluid aspiration during surgeries.

Key Players

• Abbott
• B. Braun SE
• Boston Scientific Corporation
• Integra LifeSciences Corporation
• LivaNova PLC
• Medtronic plc
• Natus Medical Incorporated
• Nihon Kohden Corporation
• Penumbra, Inc
• Stryker Corporation

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

👉Get Custom Market Research for Your Business👈

About Us

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us

IMARC Group,

134 N 4th St. Brooklyn, NY 11249, USA,

Email: sales@imarcgroup.com,

Tel No: (D) +91 120 433 0800,

United States: +1-201971-6302